Clinical Trials Directory

Trials / Completed

CompletedNCT02747277

Analysis of B Cells From Autoimmune Individuals

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This observational study aims at finding out if individual with autoimmunity exhibit increased numbers of B cells that express two types (instead of one type) of antibodies, and if B cells of individuals genetically susceptible to autoimmunity display defects in the biological process of tolerance, which removes B cells that participate in autoimmunity.

Detailed description

Peripheral blood B cells of SLE patients are analyzed by flow cytometry to determine the frequency of B cells co-expressing immunoglobulin kappa an lambda light chains. This frequency is correlated to the disease activity.

Conditions

Timeline

Start date
2016-05-01
Primary completion
2022-01-01
Completion
2022-01-01
First posted
2016-04-21
Last updated
2023-12-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02747277. Inclusion in this directory is not an endorsement.

Analysis of B Cells From Autoimmune Individuals (NCT02747277) · Clinical Trials Directory